info@quantimol.com - 1 (800) 821-7314 - Research Use Only - B2B & B2G Only - Not For Private Use
SKU:QM-0140599-01
Couldn't load pickup availability
CLZ-8 (Compound 8) is an orally active Mcl-1-PUMA interface inhibitor, with a Ki of 0.3 μM. CLZ-8 exhibits dual activity on reduce PUMA-dependent apoptosis while deactivating Mcl-1-mediated anti-apoptosis in cancer cells[1].
[678158-55-9]
C22H23N3O2S
393.5
O=C1N=C(N2CCN(CCO)CC2)S/C1=C\C3=CC=C(C4=CC=CC=C4)C=C3
Apoptosis; Bcl-2 Family
Mcl-1
99.14
DMSO : 50 mg/mL (ultrasonic)
-20°C, 3 years; 4°C, 2 years (Powder)
Room Temperature
Loading...
Total items
Product subtotal
CLZ-8 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.